Paul W. Finn

2.7k total citations · 1 hit paper
50 papers, 2.1k citations indexed

About

Paul W. Finn is a scholar working on Molecular Biology, Computational Theory and Mathematics and Spectroscopy. According to data from OpenAlex, Paul W. Finn has authored 50 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Molecular Biology, 23 papers in Computational Theory and Mathematics and 10 papers in Spectroscopy. Recurrent topics in Paul W. Finn's work include Computational Drug Discovery Methods (22 papers), Histone Deacetylase Inhibitors Research (11 papers) and Protein Structure and Dynamics (10 papers). Paul W. Finn is often cited by papers focused on Computational Drug Discovery Methods (22 papers), Histone Deacetylase Inhibitors Research (11 papers) and Protein Structure and Dynamics (10 papers). Paul W. Finn collaborates with scholars based in United Kingdom, United States and Latvia. Paul W. Finn's co-authors include Robert Brown, Jane A. Plumb, Maxwell Sehested, Nicholas B. La Thangue, Garrett M. Morris, Nagma Khan, W. Graham Richards, James W.A. Ritchie, Nicola Steele and Lydia E. Kavraki and has published in prestigious journals such as Scientific Reports, Biochemical Journal and FEBS Letters.

In The Last Decade

Paul W. Finn

49 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Determination of the class and isoform selectivity of small-molecule histone deacetylase inhibitors

2007 599 citations Nagma Khan, Paul W. Finn et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Paul W. Finn United Kingdom	21	1.6k	350	305	221	140	50	2.1k
Adam Yasgar United States	25	1.4k 0.9×	540 1.5×	286 0.9×	271 1.2×	179 1.3×	51	2.4k
Ricardo Macarrón United States	17	1.3k 0.8×	582 1.7×	153 0.5×	285 1.3×	208 1.5×	26	2.0k
Grant R. Zimmermann United States	13	2.0k 1.3×	684 2.0×	310 1.0×	313 1.4×	285 2.0×	15	3.0k
Jung‐Hsin Lin Taiwan	24	1.7k 1.1×	585 1.7×	177 0.6×	284 1.3×	180 1.3×	61	2.4k
Zhongjie Liang China	23	1.1k 0.7×	282 0.8×	147 0.5×	232 1.0×	128 0.9×	60	1.6k
Sudipto Mukherjee United States	17	1.3k 0.8×	722 2.1×	149 0.5×	250 1.1×	148 1.1×	27	1.9k
George M. Spyrou Greece	24	1.6k 1.0×	571 1.6×	297 1.0×	162 0.7×	163 1.2×	165	3.0k
Christina Kiel Spain	26	2.6k 1.7×	509 1.5×	329 1.1×	161 0.7×	155 1.1×	60	3.4k
James L. Kofron United States	15	1.4k 0.9×	429 1.2×	338 1.1×	153 0.7×	104 0.7×	23	1.7k
Jörg Eder Switzerland	22	1.5k 1.0×	367 1.0×	305 1.0×	206 0.9×	135 1.0×	41	2.4k

Countries citing papers authored by Paul W. Finn

Since Specialization

Citations

This map shows the geographic impact of Paul W. Finn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul W. Finn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul W. Finn more than expected).

Fields of papers citing papers by Paul W. Finn

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul W. Finn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul W. Finn. The network helps show where Paul W. Finn may publish in the future.

Co-authorship network of co-authors of Paul W. Finn

This figure shows the co-authorship network connecting the top 25 collaborators of Paul W. Finn. A scholar is included among the top collaborators of Paul W. Finn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul W. Finn. Paul W. Finn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Velikova, Nadya, et al.. (2024). Repurposing Hsp90 inhibitors as antimicrobials targeting two-component systems identifies compounds leading to loss of bacterial membrane integrity. Microbiology Spectrum. 12(8). e0014624–e0014624. 2 indexed citations

Ebejer, Jean-Paul, M. Charlton, & Paul W. Finn. (2016). Are the physicochemical properties of antibacterial compounds really different from other drugs?. Journal of Cheminformatics. 8(1). 30–30. 46 indexed citations

Penzo, Maria, et al.. (2014). Substrate derived peptidic α-ketoamides as inhibitors of the malarial protease PfSUB1. Bioorganic & Medicinal Chemistry Letters. 24(18). 4486–4489. 28 indexed citations

Korb, Oliver, Paul W. Finn, & Gareth Jones. (2014). The cloud and other new computational methods to improve molecular modelling. Expert Opinion on Drug Discovery. 9(10). 1121–1131. 10 indexed citations

Bryant, Drew, Mark Moll, Paul W. Finn, & Lydia E. Kavraki. (2013). Combinatorial Clustering of Residue Position Subsets Predicts Inhibitor Affinity across the Human Kinome. PLoS Computational Biology. 9(6). e1003087–e1003087. 10 indexed citations

Ebejer, Jean-Paul, Simone Fulle, Garrett M. Morris, & Paul W. Finn. (2013). The emerging role of cloud computing in molecular modelling. Journal of Molecular Graphics and Modelling. 44. 177–187. 19 indexed citations

Withers‐Martinez, Chrislaine, Catherine Suárez, Simone Fulle, et al.. (2012). Plasmodium subtilisin-like protease 1 (SUB1): Insights into the active-site structure, specificity and function of a pan-malaria drug target. International Journal for Parasitology. 42(6). 597–612. 46 indexed citations

Morris, Garrett M., et al.. (2010). ElectroShape: fast molecular similarity calculations incorporating shape, chirality and electrostatics. Journal of Computer-Aided Molecular Design. 24(9). 789–801. 63 indexed citations

Ballester, Pedro J., Paul W. Finn, & W. Graham Richards. (2009). Ultrafast shape recognition: Evaluating a new ligand-based virtual screening technology. Journal of Molecular Graphics and Modelling. 27(7). 836–845. 65 indexed citations

10.

Morris, Garrett M., et al.. (2009). Molecular similarity including chirality. Journal of Molecular Graphics and Modelling. 28(4). 368–370. 17 indexed citations

11.

Loža, Einārs, Ivars Kalvinsh, Paul W. Finn, et al.. (2008). Novel amide derivatives as inhibitors of histone deacetylase: Design, synthesis and SAR. European Journal of Medicinal Chemistry. 44(3). 1067–1085. 26 indexed citations

12.

Beck, Hans Christian, Rune Matthiesen, Lars H. Jensen, et al.. (2006). Quantitative Proteomic Analysis of Post-translational Modifications of Human Histones. Molecular & Cellular Proteomics. 5(7). 1314–1325. 164 indexed citations

13.

Plumb, Jane A., Nicola Steele, Paul W. Finn, & Robert Brown. (2004). Epigenetic approaches to cancer therapy. Biochemical Society Transactions. 32(6). 1095–1097. 25 indexed citations

14.

Finn, Paul W., et al.. (2002). The histone deacetylase inhibitor PXD101 inhibits the growth of human ovarian and colon tumour xenografts in vivo.. British Journal of Cancer. 86. 1 indexed citations

15.

LaValle, Steven M., Paul W. Finn, Lydia E. Kavraki, & Jean‐Claude Latombe. (2000). A randomized kinematics-based approach to pharmacophore-constrained conformational search and database screening. Journal of Computational Chemistry. 21(9). 731–747. 29 indexed citations

16.

Finn, Paul W., Lydia E. Kavraki, J.-C. Latombe, et al.. (1997). RAPID. 324–333. 20 indexed citations

17.

Blagg, Julian, Stephen A. Ballard, Kelvin Cooper, et al.. (1996). The development of non-steroidal dual inhibitors of both human 5α-reductase isozymes. Bioorganic & Medicinal Chemistry Letters. 6(13). 1517–1522. 9 indexed citations

18.

Finn, Paul W.. (1996). Computer-based screening of compound databases for the identification of novel leads. Drug Discovery Today. 1(9). 363–370. 14 indexed citations

19.

Barnish, I. T., et al.. (1993). Asymmetric synthesis of β-amino acid derivatives by Michael addition to chiral 2-aminomethylacrylates. Tetrahedron Letters. 34(8). 1323–1326. 22 indexed citations

20.

Finn, Paul W., et al.. (1987). Comparative conformation‐activity relationships for hormonally‐ and centrally‐acting TRH analogues. International journal of peptide & protein research. 30(2). 263–274. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact